NASDAQ:ADIL

Adial Pharmaceuticals Stock Faces Crucial AD04 Funding Test After Holiday Break
····

Adial Pharmaceuticals Stock Faces Crucial AD04 Funding Test After Holiday Break

Adial Pharmaceuticals shares fell 1.4% to $2.05 in premarket trading Tuesday, after U.S. exchanges closed Monday for Memorial Day. The company reported $4.6 million in cash as of March 31, enough to fund operations into the second half of 2026. No new company updates were released over the holiday weekend. Plans for a new Phase 3 trial of lead drug AD04 remain on hold pending additional funding.
May 26, 2026

Stock Market Today

  • UK Gilt Yields Fall Amid Political Stability and Eased Rate Hike Concerns
    May 26, 2026, 9:28 AM EDT. U.K. gilt yields declined to five-week lows as investor worries about political instability eased following Labour's local election setbacks. The 10-year gilt yield dropped to 4.85%, down about 30 basis points, reflecting reduced expectations for interest rate hikes. Prime Minister Keir Starmer, though challenged by potential rivals including Andy Burnham, remains in charge, calming markets concerned about fiscal policy shifts. Additionally, optimism surrounding a possible U.S.-Iran peace deal and the reopening of the Strait of Hormuz has eased inflation fears, further reducing yield pressures. Analysts at Pantheon Macroeconomics noted that investors are discounting weak economic data and now anticipate fewer rate increases in 2026, driving the largest weekly drop in gilt yields since late 2023.